Synergistic cytokine effects as apremilast response predictors in patients with psoriasis

被引：25
|
作者：
Garcet, Sandra [1 ]
Nograles, Kristine [2 ]
da Rosa, Joel Correa [1 ]
Schafer, Peter H. [3 ]
Krueger, James G. [1 ]
机构：
[1] Rockefeller Univ, Lab Invest Dermatol, 1230 York Ave, New York, NY 10021 USA
[2] Celgene Corp, Clin Res & Dev, Summit, NJ USA
[3] Celgene Corp, Dept Translat Dev, Summit, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 142卷 / 03期
关键词：
SEVERE PLAQUE PSORIASIS; PHOSPHODIESTERASE-4; INHIBITOR; PDE4; PHASE-III; EFFICACY; MODERATE; SAFETY;
D O I：
10.1016/j.jaci.2018.05.039
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1010 / 1013
页数：5
相关论文
共 50 条
  • [1] The effect of apremilast therapy on skin cytokine levels in patients with psoriasis
    Kubanov, Alexey A.
    Solomka, Viktoria S.
    Karamova, Arfenya E.
    Verbenko, Dmitry A.
    Vasileva, Elena L.
    Artamonova, Olga G.
    RUSSIAN OPEN MEDICAL JOURNAL, 2020, 9 (03)
  • [2] Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis
    Pincelli, Carlo
    Schafer, Peter H.
    French, Lars E.
    Augustin, Matthias
    Krueger, James G.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (08) : 835 - 840
  • [3] Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study
    Malara, Giovanna
    Politi, Cristina
    Trifiro, Caterina
    Verduci, Chiara
    D'Arrigo, Graziella
    Testa, Alessandra
    Tripepi, Giovanni
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [4] Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
    Gottlieb, Alice B.
    Merola, Joseph F.
    Cirulli, Joshua
    Williams, Catherine C.
    Linowski, Gregory J.
    Paris, Maria
    Litman, Heather J.
    Guo, Ning
    Emeanuru, Kelechi
    McLean, Robert R.
    Cronin, Angel
    Strober, Bruce
    DERMATOLOGY AND THERAPY, 2021, 11 (01) : 253 - 263
  • [5] Real-world experiences of apremilast in clinics for Japanese patients with psoriasis
    Saruwatari, Hiroshi
    JOURNAL OF DERMATOLOGY, 2019, 46 (12) : 1166 - 1169
  • [6] Combination therapy of apremilast and biologics in patients with psoriasis showing biologic fatigue
    Takamura, Saori
    Sugai, Sora
    Taguchi, Ryokichi
    Teraki, Yuichi
    JOURNAL OF DERMATOLOGY, 2020, 47 (03) : 290 - 294
  • [7] PDE4 Gene Family Variants Are Associated with Response to Apremilast Treatment in Psoriasis
    Liadaki, Kalliopi
    Zafiriou, Efterpi
    Giannoulis, Themistoklis
    Alexouda, Sofia
    Chaidaki, Kleoniki
    Gidarokosta, Polyxeni
    Roussaki-Schulze, Angeliki-Viktoria
    Tsiogkas, Sotirios G.
    Daponte, Athina
    Mamuris, Zissis
    Bogdanos, Dimitrios P.
    Moschonas, Nicholas K.
    Sarafidou, Theologia
    GENES, 2024, 15 (03)
  • [8] Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
    Graier, Thomas
    Weger, Wolfgang
    Sator, Paul-Gunther
    Salmhofer, Wolfgang
    Gruber, Barbara
    Jonak, Constanze
    Koelli, Claudia
    Schuetz-Bergmayr, Martina
    Vujic, Igor
    Ratzinger, Gudrun
    Haering, Nina
    Painsi, Clemens
    Prillinger, Knut
    Mlynek, Alexander
    Skvara, Hans
    Trattner, Hannes
    Rudolfstiftung, Vienna
    Tanew, Adrian
    Lichem, Roland
    Ellersdorfer, Christina
    Legat, Franz
    Gruber-Wackernagel, Alexandra
    Hofer, Angelika
    Schmiedberger, Erich
    Hoetzenecker, Wolfram
    Muellegger, Robert
    Saxinger, Werner
    Quehenberger, Franz
    Wolf, Peter
    JAAD INTERNATIONAL, 2021, 2 : 62 - 75
  • [9] Four-year drug survival of apremilast in patients with psoriasis
    Kishimoto, Megumi
    Komine, Mayumi
    Kamiya, Koji
    Sugai, Junichi
    Kuwahara, Aya
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2023, 50 (07) : 960 - 963
  • [10] Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis
    Garbayo Salmons, P.
    Exposito Serrano, V.
    Romani de Gabriel, J.
    Ribera Pibernat, M.
    ACTAS DERMO-SIFILIOGRAFICAS, 2022, 113 (05): : T532 - T535
12345